Healthcare >> CEO Interviews >> July 5, 2004

JULIA GREGORY – LEXICON GENETICS INC (LEXG)

JULIA P. GREGORY has been Executive Vice President, Corporate Development and Chief Financial Officer of Lexicon Genetics since August 2003 and served as Executive Vice President and Chief Financial Officer from February 2000 until August 2003. From 1998 to February 2000, Ms. Gregory served as the Head of Investment Banking for Punk, Ziegel & Company, a specialty investment banking firm focusing on technology and health care and, from 1996 to February 2000, as the Head of the firm's Life Sciences practice. From 1980 to 1996, Ms. Gregory was an investment banker, primarily with Dillon, Read & Co., Inc., where she represented life sciences companies beginning in 1986. Ms. Gregory is a member of the Board of Directors and the Scientific Advisory Board of the Estee Lauder Foundation's Institute for the Study of Aging, Inc., and a member of The International Council for George Washington University's Elliott School of International Affairs. She received her BA in International Affairs from George Washington University and her MBA from the Wharton School of the University of Pennsylvania. Profile
TWST: Give us a brief history of your company and an overview of your

operations and technology.

Ms. Gregory: Lexicon Genetics is a drug discovery company using gene

knockout technology to